ALX Oncology
ALXO
$14.21
Share price
-3.07%
Change (1 day)
125.20%
Change (1 year)
Categories
ALX Oncology (ALXO) - P/B ratio
P/B ratio as of May 2024 : 4.03
According to ALX Oncology's latest financial reports the company has a price-to-book ratio of 4.03.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ALX Oncology - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.91 | 124.29% |
| 2022-12-31 | 1.74 | -27.28% |
| 2021-12-31 | 2.40 | -67.78% |
| 2020-12-31 | 7.44 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -32.59% | 🇺🇸 USA |